Categories

Category: Health Tech

Jessica Holton, Ours Privacy

Ours Privacy was born from a particular problem that almost every digital health services company has — how do we identify the best customers without violating their privacy? CEO Jessica Holton explain to me what a pixel is, why so many hospitals and digital health companies have got in trouble, and how their solution actually improves information about customers, which is good for both the consumer and the healthcare company–Matthew Holt

This interview is part of a partnership between Ours Privacy and THCB.

Transcript

Matthew Holt: Hi, it’s Matthew Holt, The Health Care Blog. I have another THCB spotlight. I have with me today Jessica Holton. Jessica is the CEO of Ours Privacy. If you couldn’t tell, the name is behind her upper right shoulder over there. Jessica, welcome.

Continue reading…

The Mid-term Elections Will Not Resolve the Dysfunction at HHS

By STEVEN ZECOLA

Introduction.

The scientists at the Department of Health and Human Services (“HHS”) are breathing a sigh of relief given that the Democrats will be taking control of the House and Senate. For the past two years, there has been a tension within HHS between the scientific community and President Trump’s executive appointments. While Trump’s people have been “winning” the political battles over vaccines and restrictions on abortion-related treatments, they have not made much progress on modernizing the drug approval process, despite repeated promises. The approval process for promising therapies remains slow, uncertain, and resistant to change.

Managing by Press Release

Over the past year, HHS and FDA have announced initiatives involving personalized gene therapies, rare-disease development, AI-enabled healthcare, real-time clinical trials, and regulatory modernization.

Collectively, these announcements convey an agency committed to accelerating innovation. The more important issue for the public is whether these initiatives are changing how therapies move through the approval process.

From Promises to Practice

To judge whether reform is occurring, it is necessary to examine actual regulatory outcomes rather than public statements.

First, the FDA has had data for over a year showing how an innovative therapy for familial adenomatous polyposis (FAP) improves patient outcomes with minimum risk.

FAP is a genetic disorder that predisposes people to develop precancerous colon polyps. With FAP, patients will develop many colon polyps — typically over a hundred — starting at a young age. This significantly raises the lifetime risk that one of them will become cancerous. To manage this risk, healthcare providers usually recommend complete removal of the colon and sometimes the rectum, as well.

Continue reading…

Amy Bucher, Lirio Health

Lirio Health is an interesting under-the-radar company, which works with plans, providers and others to try to influence the behavior of their members and patients. Of course, everybody wants to change the behavior of human beings, and it’s been proven over the years to be very hard. Lirio probably has more PhDs per square foot than any other company in this sector. I spoke with one of them, the Chief Behavior Officer, Amy Bucher, and she showed me a wide variety of case studies in which they are using a wording approach and psychographics to nudge people to better behaviors. A great discussion on how and whether we can use psychology to improve health.–Matthew Holt

The transcript (made by Youtube and Claude so blame AI for any mistakes!)

Continue reading…

Stop Testing AI Against Doctors. Test Doctors With AI.

Manuel Pinilla

By MANUEL PINILLA

Every few months a new study reports that an AI model has outperformed doctors on a set of diagnostic cases. The latest one I’ve read came out in Science in October: Microsoft’s MAI-DxO, tested on 304 complex cases from the New England Journal of Medicine and run as step-by-step simulations, reached the correct diagnosis in about 83% of them. Primary care doctors and general internists, working on their own with reference materials, got 36%. Microsoft says the next step is a study with real patients.

I build clinical AI, so these results matter to my work, but they answer a different question from mine. In the setting we work on, emergency departments and primary care, a doctor will be in the room, and that doctor signs the diagnosis and answers for it. While that is the case, a score of AI against doctors tells me little about whether a tool helps. What I need to know is whether the doctor, with the AI, gets the diagnosis right more often, and what happens when the AI is wrong.

There is a second gap. A published case arrives already written up: the history is complete, the relevant findings are there and the question is clear. A real patient tells the story out of order, leaves out what they don’t think matters and sometimes can’t put into words what they feel. Getting from that to a good differential is a large part of a doctor’s job, and a benchmark mostly skips it. How a tool behaves in a specific setting, with the information that setting really provides, matters as much as what the model knows.

Where the AI shows up in the consultation

I’m an engineer, not a physician, and when I think about these tools my first concern is the interaction more than the model. To use a chatbot during a consultation, a doctor has to stop, summarize the case, write a question, read the answer and judge how far to trust it before turning back to the patient. In a ten-minute primary care visit or a crowded emergency department there is rarely time for that, so in practice the tool tends to be consulted afterwards, to check a diagnosis that is already more or less settled. By then the patient has left, and with them the chance to ask a different question or examine something that was missed.

That is the problem we set out to work on at Medsys AI, a startup in Madrid. Our assistant listens to the consultation and, as it goes on, suggests diagnostic hypotheses, questions worth asking and things to check in the physical examination. The suggestions are updated as new information comes up, and the doctor doesn’t have to type anything. What to do with them is the doctor’s call. The picture I had in mind was an attending standing behind a resident who is unsure, available to doctors at any stage of their career.

A couple of design decisions follow from that. The assistant shows several hypotheses with the reasoning behind each, drawn from more than a thousand clinical guidelines and checked by more than one model before they reach the screen. And the system is built so that we can change the underlying model and rerun our evaluations when a better one appears.

Continue reading…

Putting the “AI” in “Legal” (and “Health Care”)

By KIM BELLARD

I once again have to thank The New York Times for introducing me to a new concept. Sarah Kessler wrote about the rise of “legal engineering” – for which, it turns out, one doesn’t have to be either a lawyer or an engineer.

Their role is to help integrate A.I. into the practice of law, whether at law firms or companies. That sure sounds like a prudent, if possibly belated, idea – and one suspects we’re going to see such “engineers” in other fields. I certainly hope that healthcare is one of them, sooner rather than later.

Irene Liu, the executive director of the A.I. initiative at Stanford Law School, explained the job to Ms. Kessler thusly: “If you were to just put it into an equation, it’s law plus technology plus business process.” That Venn diagram gets pretty small very quickly.

Mary O’Carroll, the C.E.O. of LegalEng Consulting Group, also explained the role to Ms. Kessler: “You don’t necessarily need a giant pyramid of lawyers anymore. People who have this kind of skill set don’t have to have a J.D., and they don’t have to be software engineers, but there’s business process re-engineering, or this M.B.A. type skill, that I think is really necessary.”

Ms. Kessler notes that they are sometimes referred to as “knowledge and innovation counsels,” “innovation attorneys,” or “legal applications engineers,” which may illustrate that the role is both new and evolving.

If you’re considering why this role is important, note that the 2026 Legal Industry Report from 8am™ found that 69% of legal professionals report personally using Generative AI (GenAI) tools such as ChatGPT, Gemini, or Claude for work-related purposes, up from 31% a year earlier.

Continue reading…

I’d Like Some Choices, Please

By KIM BELLARD

Let’s say your favorite social media platform is bought by a right wing trillionaire, who espouses free speech, but only when it echoes his. You can switch to, say, Threads, but – whoops – that’s owned by Mark Zuckerberg, another of the super-rich who have turned to the right. There’s always Facebook but – damn! – Zucked again! So you migrate to Bluesky, where the discourse is more civil but the audiences admittedly smaller. At least you have some choices.

Not so much if, say, you are the President of Ukraine. Ukraine has unexpectedly held off the much bigger Russia for over four years now, in the process reinventing modern warfare by turning it from the traditional men, tanks, and artillery to a technology-powered war, especially with drones. To do so, it relied heavily on Starlink and its Pentagon-version Starshield. Unfortunately, Ukraine was blindsided a couple weeks ago when Starlink speeds were drastically lowered. Drones were literally falling out of the sky.

President Zelensky raised the alarm. Secretary of State Rubio said he thought software “glitches” were to blame, but most people suspected either Starlink’s owner Elon Musk and/or President Trump. Mr. Musk pointed fingers at the Pentagon, President Trump blamed Mr. Musk, and for several days Ukraine was hampered. Finally Mr. Musk admitted he’d ordered the slowdown, saying Ukraine had violated the “terms of service” of the service, using it “for offensive drone strikes to kill people.”

Note that Serhii Beskrestnov, a Ukrainian presidential adviser on military technology, wrote on social media “we are PHYSICALLY UNABLE TO USE COMMERCIAL STARLINK for deep strikes or medium-range strikes.”

The “loophole was closed last week,” according to both Mr. Musk and President Zelensky, with normal speeds resumed, but if you were President Zelensky you’d sure have to be looking for alternatives, as you’d never know when the equally mercurial Mr. Musk or President Trump might pull another Lucy on you (Gen Z: check your “Peanuts” references).

Unfortunately, there really aren’t any, and that’s a problem.

Continue reading…

HCAHPS 2.0 Is Not a Survey Update. It’s a Strategic Shift for Healthcare

By XAVIER WARTELLE

The Metric Healthcare Could Never Move

One statistic should capture the attention of every hospital executive. A peer-reviewed analysis published in Medical Care examined HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) performance across nearly 4,000 U.S. hospitals over an eleven-year period. Nearly every measured category improved meaningfully except one. Overall hospital ratings improved. Nurse communication improved. Discharge information improved.

Physician communication barely moved.

After more than a decade of public reporting, value-based purchasing incentives, star ratings, communication training, and patient experience initiatives, physician communication improved by just 0.8 percentage points, the smallest gain of any major HCAHPS domain. That finding should force healthcare leaders to ask an uncomfortable question: What if the industry’s approach to physician communication has reached its limits?

Many health systems have invested heavily in communication training, service excellence programs, scripting initiatives, and patient experience workshops. These efforts have value. But they largely focus on behavior. HCAHPS 2.0 suggests that behavior alone may no longer be enough. What if the real challenge was the antiquated tools provided to physicians that haven’t changed in nearly 50 years?

And HCAHPS 2.0 will put an even greater emphasis on this. For years, patient experience metrics largely focused on satisfaction. Did patients feel respected? Were they treated courteously? Did they have a positive overall impression of their hospital stay? Those questions remain important, but the updated framework moves beyond satisfaction and toward something far more consequential – understanding.

The new methodology places greater emphasis on care coordination, communication across care teams, family involvement, and post-discharge planning. At the same time, CMS is moving away from a scoring model that rewards only top-performing responses and toward one that recognizes incremental improvement across the entire patient population. Every improvement now matters. Every patient interaction counts. Every conversation has measurable value.

Continue reading…

What Good Is Health Coverage If You Cannot Get to the Doctor

By JOE MKHITARYAN

We spend a lot of time talking about who has health insurance. I think we need to spend more time asking who can actually use it.

You can approve an appointment, find a specialist and cover the treatment. But if the patient cannot get out of the house and into the right vehicle, none of that gets them to the doctor.

I have been in the medical transportation business since 2010. I built my businesses in Southern California, where a few miles on a map can turn into a long trip in traffic. Running these operations has taught me to ask questions that are easy to miss when you are looking at a transportation budget.

Can the patient walk? Can they sit upright? Are there stairs outside the home? Do they need a wheelchair vehicle or a gurney? Who is bringing them back?

Those answers determine whether the ride will work. They need to be settled before a vehicle arrives.

Non-emergency medical transportation, or NEMT, is how many patients reach appointments when they cannot get there on their own. It is easy to describe it as a ride. Providing it is more involved.

Take a gurney trip. In our operation, that means sending two staff members. They have to help the patient safely, load and secure the gurney, make the trip and complete the handoff. Then there is the return. That crew is working well before the vehicle starts moving and after it stops.

If you price that trip mainly by the miles driven, you leave a lot of the work out of the calculation.

I pay attention to this because I am the one paying wages, insurance and vehicle expenses. I have a business interest in the rates. But anyone responsible for patient access should care whether those rates can support the service they expect. You cannot keep asking for trained staff and dependable vehicles without considering what it costs to provide them.

Of course, paying more does not automatically produce better service. Providers should have to show that they are safe, reliable and doing the work they bill for. The question is whether the payment and the expectations make sense together.

The need is real.

Continue reading…

Big Bucks, No Whammies, Part 2: So You Won. Now What?

By STEPHEN FARBER

Part one argued that patient access was never the finish line; it was the foundation. This is about what we build now that we are standing on it.

Every good game show has a second round, and the second round is always harder. The first round was about getting health information out of the buildings that held it. Regulation, standards, and a decade of unglamorous plumbing have brought us to an important threshold. Individuals can increasingly pull records from multiple institutions into one place. The board paid out. The audience cheered.

Then a quieter and stranger question arrives. You are holding years of visits, laboratory results, medications, and discharge summaries, and you realize that having your history in one place is not the same as understanding it. Assembly was the first hard problem, but it was not the last.

The record is finally readable

This is where artificial intelligence walks onto the stage, and the promise is real. Few clinicians have time to read a patient’s entire history every time a decision must be made. Appropriately safeguarded AI can summarize years of encounters, support medication reconciliation, explain a laboratory trend in ordinary language, and surface a pattern buried across multiple providers. Large consumer platforms have already begun connecting AI assistants to medical records; Amazon’s Health AI, for example, draws on a person’s One Medical history to provide personalized explanations and guidance. Once the record can be assembled, a capable assistant can finally make more of it legible.

Legibility, however, is not reliability. The farther AI moves from explaining a record toward acting on it, the thinner the evidence becomes. A 2026 scoping review of agentic AI in healthcare found that most of the available studies were exploratory and lacked robust clinical validation, and that only one trial involved patients. An assistant working from an incomplete, duplicated, or subtly wrong record can produce a fluent and plausible conclusion that is still wrong. AI does not make data quality less important. It makes the consequences of poor data quality harder to ignore.

AI cannot read what was never written

There is a more fundamental limitation, and it has less to do with the model than with the record itself. A longitudinal record can tell us what happened, but it rarely tells us enough about why. It preserves the encounter, the diagnosis, the result, and the prescription while losing much of the reasoning that surrounded them. Why was one treatment chosen over another? What was the person hoping to preserve at that point in life? Who else was helping? What changed after the visit, and what did a family member notice before anyone thought to schedule another one?

Continue reading…

Is Your AI Query Tool Compliant by Default?

By BRIAN FENGLER

Every night in the emergency department, the electronic health record hums with small demands for attention. A nudge about sepsis. A best-practice advisory. A documentation suggestion that arrives between patients and asks for one more click.

Most of us treat those prompts as background noise. Almost none of us stop to ask whether a given nudge is, in fact, a query, or whether it was built to the same standard a clinical documentation specialist has to meet.

In August, that question got an official answer. And it is not the answer many health IT vendors have been selling.

The American Health Information Management Association and the Association of Clinical Documentation Integrity Specialists released the 2026 update to their Guidelines for Achieving a Compliant Query Practice, shaped by feedback from nearly 200 individuals and groups. The principle is plain: “Whether a query comes from a person or technology, the standard for compliance should remain the same.”

Then comes the sentence that should end a familiar sales claim: “Organizations should not assume that a vendor-supplied or EHR-integrated tool produces compliant queries by default.”

For years, “compliant by default” functioned as an unspoken promise around AI-enabled clinical documentation and utilization review tools.

Continue reading…